- Home
- MIRM vs FITBO Comparison
MIRM vs FITBO Comparison
Compare MIRM & FITBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIRM | FITBO |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | United States |
| Employees | N/A | 18676 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | N/A |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | MIRM | FITBO |
|---|---|---|
| Price | $99.61 | $18.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $119.85 | N/A |
| AVG Volume (30 Days) | ★ 632.8K | 19.5K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.59 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,138,000.00 | N/A |
| Revenue This Year | $26.22 | N/A |
| Revenue Next Year | $22.04 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $47.89 | $18.23 |
| 52 Week High | $114.99 | $21.40 |
Technical Indicators
Market Signals| Indicator | MIRM | FITBO |
|---|---|---|
| Relative Strength Index (RSI) | 53.73 | 34.58 |
| Support Level | $95.68 | $18.23 |
| Resistance Level | $107.51 | $18.76 |
| Average True Range (ATR) | 4.25 | 0.15 |
| MACD | 0.20 | 0.00 |
| Stochastic Oscillator | 77.87 | 24.53 |
Price Performance
Historical ComparisonAbout MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
About FITBO Fifth Third Bancorp Depositary Shares each representing a 1/1000th ownership interest in a share of Non-Cumulative Perpetual Preferred Stock Series K
Fifth Third Bancorp is a midsize regional bank in the US, with total assets of around $300 billion as of March 2026. The bank closed its acquisition of Comercia in February 2026. Headquartered in Cincinnati, Ohio, Fifth Third has a strong presence in the US Midwest and is currently expanding in the US Southeast. The bank provides a diversified set of financial services in retail banking, commercial banking, card and Treasury management, wealth and asset management, and capital markets.